Who owns the REP360 trademark?

The REP360 trademark is owned by BioPharm Communications, LLC.

What class is the REP360 trademark registered in?

The REP360 trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for REP360?

The USPTO serial number for REP360 is 97295551.

What is the registration number for REP360?

REP360 is registered under USPTO registration number 7008075.

Sealvo

Home Search: REP360REP360 #97295551

Back

Updated Oct 9, 2026·18 searches this week

View on USPTO TSDR Find similar marks

REP

USPTO Trademark Record

REGISTERED

REP360

SN 97295551·Reg 7008075·Filed Mar 04, 2022

Owner BioPharm Communications, LLC

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

REP360 (Serial No. 97295551), Registration No. 7008075, is a registered US trademark filed on Mar 04, 2022 by BioPharm Communications, LLC. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: March 21, 2029

Mark Intelligence

REP360 (Reg. #7008075) is a registered US trademark that has been protecting its owner, BioPharm Communications, LLC, since 2022. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 04, 2022

SERIAL

97295551

REG#

7008075

REGISTERED

Mar 21, 2023

Filing Information

StatusREGISTERED

Filing DateMar 04, 2022

Serial Number97295551

Registration No.7008075

Registration DateMar 21, 2023

Status DateMar 21, 2023

Published for OppositionMay 17, 2022

Filing Basis & Declarations

Standard Characters ClaimedUse Application Currently

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Nov 30, 2022

First use in commerce: Nov 30, 2022

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

16 events

REGISTERED-PRINCIPAL REGISTER

Mar 21, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 21, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Feb 15, 2023

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Feb 14, 2023

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Jan 25, 2023

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 24, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Dec 21, 2022

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Dec 21, 2022

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 12, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

May 17, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 17, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 27, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 12, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Apr 05, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 09, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Mar 08, 2022

NEW APPLICATION ENTERED

Other Marks by BioPharm Communications, LLC

Additional USPTO filings from the same owner.

ACC

ACCESSADVISOR

88041039

BioPharm Communications, LLC

REGISTERED

EXP

EXPERT PERSPECTIVES CONFERENCE REPORTER

88978475

BioPharm Communications, LLC

REGISTERED

CLI

CLINBRIEFS

88042639

BioPharm Communications, LLC

REGISTERED

SOL

SOLVE REAL MARKETING CHALLENGES, SIMPLY.

98258446

BioPharm Communications, LLC

REGISTERED

REP360

Run a conflict check

Other Marks by BioPharm Communications, LLC

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company